Dr. Brammer on Brentuximab Vedotin for Patients With T-Cell Lymphoma | OncLive
Dr. Brammer on Brentuximab Vedotin for Patients With T-Cell Ly…
Oct 26, 2017
onclive.com
Polatuzumab Vedotin for 1L DLBCL: Results From the POLARIX Trial
Polatuzumab Vedotin for 1L DLBCL: Results From the POLARIX Trial
368 viewsJun 26, 2024
vumedi.com
Improved OS With 1L Brentuximab Vedotin Chemo in Stage III/IV Classical Hodgkin Lymphoma: 6-Year Analysis of ECHELON-1
Improved OS With 1L Brentuximab Vedotin Chemo in Stage III/IV Clas…
Jul 26, 2022
vumedi.com
A combination of brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine has been shown to improve progression-free survival in Hodgkin's lymphoma. Data on overall survival are needed. New research findings are summarized in a short video. https://nej.md/3BciZAQ | The New England Journal of Medicine
2:15
A combination of brentuximab vedotin plus doxorubicin, vinblast…
3.7K viewsJul 27, 2022
FacebookThe New England Journal of Medicine
In high-risk Hodgkin’s lymphoma, brentuximab vedotin in combination with chemotherapy has shown greater efficacy than chemotherapy alone, but at the cost of increased toxic effects. New research findings are summarized in a short video. https://nej.md/3sBHguB | The New England Journal of Medicine
2:16
In high-risk Hodgkin’s lymphoma, brentuximab vedotin in combinati…
1.6K viewsOct 31, 2022
FacebookThe New England Journal of Medicine
Seattle Genetics : Announces Health Canada Approval of ADCETRIS® (Brentuximab Vedotin) in Combination with Chemotherapy in Frontline CD30-Expressing Peripheral T-Cell Lymphoma
Seattle Genetics : Announces Health Canada Approval of ADCETRIS® (…
Nov 25, 2019
marketscreener.com
Up to 40% of patients receiving the standard R-CHOP regimen for diffuse large B-cell lymphoma have refractory disease or relapse. A modified regimen might improve outcomes. New research findings are summarized in a short video. https://nej.md/3rSJ41d | The New England Journal of Medicine
2:12
Up to 40% of patients receiving the standard R-CHOP regimen for diff…
5.6K viewsJan 27, 2022
FacebookThe New England Journal of Medicine
ECHELON-1 Trial: Brentuximab Vedotin With Chemotherapy Offer…
Aug 8, 2022
ascopost.com
0:46
How to Pronounce Force Majeure? (CORRECTLY) English, American, …
153.9K viewsApr 24, 2020
YouTubeJulien Miquel
1:25
Dr. Brammer on Brentuximab Vedotin for Patients With T-Cell Ly…
303 viewsOct 26, 2017
YouTubeOncLive
1:19
Dr. Smith Discusses Brentuximab Vedotin in CTCL
367 viewsJul 20, 2018
YouTubeOncLive
6:13
Brentuximab Vedotin
2.8K viewsSep 14, 2016
YouTubeOncLive
1:47
Brentuximab vedotin for CTCL
149 viewsOct 15, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:00
Current treatment landscape of DLBCL
480 viewsAug 30, 2020
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:30
Brentuximab vedotin for CTCL
252 viewsOct 15, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
57:51
【第12回】血液がん知っとかナイト「びまん性大細胞型B細胞リンパ腫(…
9.8K viewsFeb 14, 2025
YouTubeCancer Channel
5:16
Drug Development: Brentuximab Vedotin
1.5K viewsMar 24, 2022
YouTubeCutaneousLymphomaFnd
1:36
The current treatment landscape for T-cell lymphoma
1.1K viewsJun 16, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:47
Dr. Hamlin Discusses Integrating Brentuximab Vedotin
827 viewsFeb 10, 2012
YouTubeOncLive
0:56
PACIFIC: Brentuximab vedotin in mediastinal DLBCL
186 viewsFeb 2, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:46
ALCANZA: brentuximab vedotin for CTCL
166 viewsOct 14, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:14:30
リンパ腫カレッジ2024 #1「びまん性大細胞型B細胞リンパ腫（DLBCL…
22.5K viewsAug 27, 2024
YouTubeネクサス・チャンネル
5:46
Glofitamab and polatuzumab vedotin in DLBCL
811 viewsFeb 2, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
0:51
Dr. Advani Discusses Front-Line Brentuximab
447 viewsMay 6, 2013
YouTubeOncLive
4:01
First- and second-line treatment in DLBCL
2.1K viewsMay 6, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:39
Treatment Alternatives to Chemotherapy in R/R DLBCL
765 viewsFeb 18, 2020
YouTubeOncLive
2:11
Dr. Zelenetz Discusses CD30 as a Target in Lymphoma
383 viewsDec 18, 2012
YouTubeTargeted Oncology
6:57
Brentuximab Vedotin in CD30-Positive Lymphoma
2.7K viewsMar 12, 2014
YouTubeOncLive
2:28
Nivolumab in Advanced Hodgkin’s Lymphoma | NEJM
3.4K viewsOct 18, 2024
YouTubeNEJM Group
0:06
How to pronounce Brentuximab vedotin
154 viewsMay 11, 2022
YouTubePharmX
See more videos
Static thumbnail place holder